Hodgen, G. D., & diZerega, G. S. (1981). Follicular phase treatment of luteal phase dysfunction. Fertility and Sterility, 35(4), 428-432. https://doi.org/10.1016/s0015-0282(16)45438-5
Hodgen GD, diZerega GS. Follicular phase treatment of luteal phase dysfunction. Fertil Steril. 1981;35(4):428-432. doi:10.1016/s0015-0282(16)45438-5
Hodgen, G. D., and G. S. diZerega. "Follicular phase treatment of luteal phase dysfunction." Fertility and Sterility, vol. 35, no. 4, 1981, pp. 428-432.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Free to read at the publisher (reported by Unpaywall and OpenAlex, not verified by RRM Academy)
Early FSH treatment partly preserved luteal function in monkeys
Early FSH treatment appears to partly preserve luteal function in monkeys with induced FSH deficiency. This 1981 experiment used 10 adult rhesus monkeys in two groups of five. With the lower dose of the FSH-suppressing fluid, each cycle had one timely ovulation. In the higher-dose group, none of the monkeys ovulated.
Key Findings
In the five monkeys given low-dose follicular fluid plus FSH-rich hMG, surgical inspection on cycle day 16 confirmed single ovulations on cycle days 13 to 15.
The low-dose group's intermenstrual interval was 26.3 ± 2.4 days (mean ± standard error). Its initial luteal progesterone rise resembled normal ovulatory cycles, and late luteal progesterone stayed below normal.
In the five monkeys given high-dose follicular fluid plus hMG, FSH stayed below normal and estradiol fell markedly (P < 0.05). No corpus luteum developed, and progesterone stayed at basal levels.
Estradiol also declined in the low-dose group (P < 0.05), yet stayed significantly higher than in the high-dose group (P < 0.05).
Radioimmunoassay LH levels were unaffected by follicular fluid in the low-dose group and not significantly affected in the high-dose group.
Interpretation
This experiment gave adult rhesus monkeys one of two doses of FSH-suppressing follicular fluid, five monkeys per dose. The low dose allowed ovulation. Early luteal progesterone rose much like a normal cycle, but late luteal progesterone stayed below normal. The high dose suppressed FSH further. No corpus luteum formed, and progesterone stayed at baseline levels. The authors note that proving full normal corpus luteum function would require restored hCG response and normal fertility rates. The authors call for clinical studies of this approach in infertility linked to some types of luteal phase problems.
RRM Context
This paper shows that early follicular-phase FSH levels shape how the corpus luteum later forms and works. Low progesterone after ovulation can point back to the follicular phase as a place to look for the cause. Restorative reproductive medicine reads the whole cycle as one connected system. Fertility awareness charting tracks how long the luteal phase lasts.
Our editorial summary of this paper, not the article's abstract.
Abstract
Previously, we demonstrated that selective suppression of serum follicle-stimulating hormone (FSH) in monkeys treated with charcoal-extracted porcine follicular fluid (pFF) in the early follicular phase induced luteal defects resembling those which occur spontaneously in women and monkeys. Here, we assessed whether luteal phase defects arising in association with induced FSH deficiencies during the early follicular phase can be treated by early FSH therapy. Rhesus monkeys were treated with pFF and human menopausal gonadotropin (hMG) (FSH:luteinizing hormone [LH], 3:1) on cycle days 1 to 3 or day 4, respectively. Daily femoral blood samples were analyzed for LH, FSH, and estradiol by radioimmunoassay. In the monkeys treated with the pFF-hMG combination, a single ovulation was uniformly noted at laparoscopy, and initial luteal phase elevations in serum progesterone levels were nearer those of normal ovulatory cycles than after pFF alone. These results suggest that FSH/LH treatment in the early follicular phase compensated, in part, for the pFF-induced deficiency in endogenous FSH levels.